Zbigniew Morawiec Selected Research

Zbigniew Morawiec Research Topics

Disease

21	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2003
15	Neoplasms (Cancer) 01/2018 - 10/2004
3	Neoplasm Metastasis (Metastasis) 07/2016 - 01/2006
3	Genomic Instability 12/2010 - 01/2003
2	Pathologic Complete Response 07/2012 - 05/2012
2	Leukemia 07/2008 - 11/2006
2	Stomach Neoplasms (Stomach Cancer) 10/2006 - 01/2006
1	Ductal Carcinoma 07/2016
1	Triple Negative Breast Neoplasms 05/2014
1	Margins of Excision 02/2014
1	Rectal Neoplasms (Rectal Cancer) 12/2012
1	Fever of Unknown Origin 12/2012
1	Wounds and Injuries (Trauma) 12/2012
1	Lymphatic Metastasis 12/2008
1	Rhabdomyosarcoma 08/2008
1	Sarcoma (Soft Tissue Sarcoma) 08/2008
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2008
1	Carcinoma (Carcinomatosis) 06/2007
1	Infections 01/2006

Drug/Important Bio-Agent (IBA)

10	DNA (Deoxyribonucleic Acid)IBA 12/2010 - 01/2003
3	EnzymesIBA 10/2015 - 12/2010
3	Estrogens (Estrogen)FDA Link 08/2009 - 01/2006
3	Progesterone Receptors (Progesterone Receptor)IBA 08/2009 - 01/2006
3	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2008 - 10/2004
3	MutagensIBA 10/2006 - 10/2004
2	Messenger RNA (mRNA)IBA 01/2018 - 07/2016
2	Hormones (Hormone)IBA 10/2016 - 12/2007
2	Matrix Metalloproteinases (MMPs)IBA 07/2016 - 01/2006
2	AntioxidantsIBA 10/2015 - 07/2007
2	MicroRNAs (MicroRNA)IBA 09/2014 - 05/2014
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2003
2	Tamoxifen FDA LinkGeneric 08/2008 - 07/2007
2	Pharmaceutical PreparationsIBA 08/2008 - 10/2004
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2008 - 11/2006
2	Imatinib Mesylate (Gleevec)FDA Link 07/2008 - 11/2006
2	Methylnitronitrosoguanidine (MNNG)IBA 01/2008 - 01/2006
2	Codon (Codons)IBA 06/2007 - 12/2005
1	Estrogen Receptor alphaIBA 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	Glutathione Peroxidase GPX1IBA 01/2018
1	Biological ProductsIBA 10/2016
1	Cysteine Proteases (Cysteine Protease)IBA 10/2016
1	Ceruloplasmin (Ferroxidase)IBA 10/2015
1	Thiobarbituric Acid Reactive SubstancesIBA 10/2015
1	prolyl-proline (Pro-Pro)IBA 10/2015
1	Glutathione PeroxidaseIBA 10/2015
1	Trace Elements (Biometals)IBA 10/2015
1	SeleniumIBA 10/2015
1	Programmed Cell Death 1 ReceptorIBA 08/2015
1	CTLA-4 AntigenIBA 08/2015
1	Phenobarbital (Luminal)FDA Link 02/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2012
1	Gentamicins (Gentamicin)FDA LinkGeneric 12/2012
1	Caspase 3 (Caspase-3)IBA 07/2012
1	AnthracyclinesIBA 07/2012
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 07/2012
1	Biomarkers (Surrogate Marker)IBA 07/2012
1	Transforming Growth Factor beta3 (TGF beta 3)IBA 07/2012
1	Taxoids (Taxanes)IBA 07/2012
1	Cisplatin (Platino)FDA LinkGeneric 05/2012
1	NucleotidesIBA 10/2010
1	lysyllysine (Lys-Lys)IBA 12/2008
1	Anastrozole (Arimidex)FDA LinkGeneric 08/2008
1	MelatoninIBA 12/2007
1	Amifostine (Ethyol)FDA LinkGeneric 07/2007
1	Free RadicalsIBA 07/2007
1	AlkaliesIBA 07/2007
1	prolylarginineIBA 06/2007
1	DNA Polymerase beta (DNA Polymerase IV)IBA 06/2007
1	methionylmethionine (Met-Met)IBA 06/2007
1	CarcinogensIBA 01/2006
1	AntigensIBA 01/2006
1	NitrosaminesIBA 01/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2004
1	5' Untranslated Regions (5' UTR)IBA 01/2003

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 09/2014 - 10/2004
3	Therapeutics 05/2014 - 12/2012
2	Neoadjuvant Therapy 07/2012 - 05/2012
1	Adjuvant Chemotherapy 02/2014
1	Radiotherapy 02/2014
1	Proctectomy 12/2012
1	Chemoprevention 07/2007
1	Aftercare (After-Treatment) 10/2004